Mackley MP, Fletcher B, Parker M, Watkins H, Ormondroyd E. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies. Genet Med. 2017;19(3):283–93.
Delanne J, Nambot S, Chassagne A, Putois O, Pelissier A, Peyron C, et al. Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives: a review of the literature. Eur J Med Genet. 2019;62(6):103529.
Article CAS PubMed Google Scholar
Cléophat JE, Dorval M, El Haffaf Z, Chiquette J, Collins S, Malo B, et al. Whether, when, how, and how much? General public’s and cancer patients’ views about the disclosure of genomic secondary findings. BMC Med Genomics. 2021;14(1):1–13.
Christenhusz GM, Devriendt K, Dierickx K. Disclosing incidental findings in genetics contexts: a review of the empirical ethical research. Eur J Med Genet. 2013;56(10):529–40.
Allyse MA, Meagher KM, Michie M, Isasi R, Ormond KE, Bonhomme N, et al. Translational justice in human gene editing: bringing end user engagement and policy together. Am J Bioeth. 2023;23(7):55–8.
Hull SC, Brody LC, Sterling R. Getting it right: how public engagement might (and might not) help us determine what is equitable in genomics and precision medicine. Am J Bioeth. 2023;23(7):5–8.
Hiromoto K, Yamada T, Tsuchiya M, Kawame H, Nanba E, Goto Y, et al. Challenges of secondary finding disclosure in genomic medicine in rare diseases: a nation-wide survey of Japanese facilities outsourcing comprehensive genetic testing. J Hum Genet. 2023;68(1):1–9.
Robinson JO, Wynn J, Biesecker B, Biesecker LG, Bernhardt B, Brothers KB, et al. Psychological outcomes related to exome and genome sequencing result disclosure: a meta-analysis of seven Clinical Sequencing Exploratory Research (CSER) Consortium studies. Genet Med. 2019;21(12):2781–90.
Article PubMed PubMed Central Google Scholar
Jiang S. A scoping review of global guidelines for the disclosure of secondary genomic findings to inform the establishment of guidelines in China. China CDC Weekly. 2022;4(32):697–705.
PubMed PubMed Central Google Scholar
Bergner AL, Bollinger J, Raraigh KS, Tichnell C, Murray B, Blout CL, et al. Informed consent for exome sequencing research in families with genetic disease: the emerging issue of incidental findings. Am J Med Genet A. 2014;164(11):2745–52.
Saelaert M, Mertes H, Moerenhout T, De Baere E, Devisch I. Ethical values supporting the disclosure of incidental and secondary findings in clinical genomic testing: a qualitative study. BMC Med Ethics. 2020;21:1–12.
Directors AB. Laboratory and clinical genomic data sharing is crucial to improving genetic health care: a position statement of the American College of Medical Genetics and Genomics. Genet Med. 2017;19(7):721–2.
Miller DT, Lee K, Gordon AS, Amendola LM, Adelman K, Bale SJ, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021;23(8):1391–8.
Kalia SS, Adelman K, Bale SJ, Chung WK, Eng C, Evans JP, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics. Genet Med. 2017;19(2):249–55.
Ghaly M, Sadoun E, Alkuraya F, Fakhro K, Ismail S, Ben-Omran T. Genomics in the Gulf region and islamic ethics. Genomics. 2016; 4(01).
Aloraini T, Abdulrahim A, Karbani GA. Attitudes of geneticists and patients toward incidental findings in Saudi Arabia. IRB. 2019;37:17.
El Shanti H, Chouchane L, Badii R, Gallouzi IE, Gasparini P. Genetic testing and genomic analysis: a debate on ethical, social and legal issues in the Arab world with a focus on Qatar. J Transl Med. 2015;13(1):1–10.
Al Mahairi ZN. Pharmacogenomics in the emirati population: applications in cardiovascular diseases and oncology. 2020.
American Society of Health-System P. ASHP statement on the pharmacist’s role in clinical pharmacogenomics. Am J Health-Syst Pharm. 2015;72(7):579–81.
Johnson SG. Leading clinical pharmacogenomics implementation: advancing pharmacy practice. Am J Health Syst Pharm. 2015;72(15):1324–8.
Barajas M, Ross LF. Pediatric professionals’ attitudes about secondary findings in genomic sequencing of children. J Pediatr. 2015;166(5):1276-82.e7.
Bartos MN. Attitudes on pharmacogenetic results as secondary findings among genetics providers: Icahn School of Medicine at Mount Sinai; 2021.
Gammal RS, Mayes J, Caudle KE. Ready or not, here it comes: direct-to-consumer pharmacogenomic testing and its implications for community pharmacists. J Am Pharm Assoc. 2019;59(5):646–50.
Tuteja S, Haynes K, Zayac C, Sprague JE, Bernhardt B, Pyeritz R. Community pharmacists ‘attitudes towards clinical utility and ethical implications of pharmacogenetic testing. Pers Med. 2013;10(8):793–800.
Mavroidopoulou V, Xera E, Mollaki V. Awareness, attitudes and perspectives of direct-to-consumer genetic testing in Greece: a survey of potential consumers. J Hum Genet. 2015;60(9):515–23.
Pop C, Cristina A, Iaru I, Popa SL, Mogoșan C. Nation-wide survey assessing the knowledge and attitudes of Romanian pharmacists concerning pharmacogenetics. Front Pharmacol. 2022;13:952562.
Article PubMed PubMed Central Google Scholar
Arafah A, Rehman MU, Syed W, Babelghaith SD, Alwhaibi A, Al Arifi MN. Knowledge, attitude and perception of pharmacy students towards pharmacogenomics and genetics: an observational Study from King Saud University. Genes. 2022;13(2):269.
Article CAS PubMed PubMed Central Google Scholar
Hu X, Jia T, Zhang X, Wu C, Zhang Y, Chen J, et al. Clinical pharmacists’ involvement in pharmacogenomics testing and related services in China. J Personal Med. 2022;12(8):1267.
Nie X, Jia T, Hu X, Li S, Zhang X, Wu C, et al. Clinical pharmacists’ knowledge of and attitudes toward pharmacogenomic testing in China. J Personal Med. 2022;12(8):1348.
Mills R, Haga SB. Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists. Pharmacogenomics. 2013;14(8):957–68.
Article CAS PubMed Google Scholar
Eysenbach G. Improving the quality of Web surveys: the checklist for reporting results of internet E-Surveys (CHERRIES). Gunther Eysenbach Centre for Global eHealth Innovation, Toronto, Canada; 2004. p. e34.
R Core Team R. R: A language and environment for statistical computing. 2013.
Abdela OA, Bhagavathula AS, Gebreyohannes EA, Tegegn HG. Ethiopian health care professionals’ knowledge, attitude, and interests toward pharmacogenomics. Pharmacogenom Personal Med. 2017;10:279–85.
Adams SM, Anderson KB, Coons JC, Smith RB, Meyer SM, Parker LS, et al. Advancing pharmacogenomics education in the core PharmD curriculum through student personal genomic testing. Am J Pharm Edu. 2016;80(1):3.
Albassam A, Alshammari S, Ouda G, Koshy S, Awad A. Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait. PLoS ONE. 2018;13(9):e0203033.
Article PubMed PubMed Central Google Scholar
AlEjielat R, Ejielat Z, Andrawes S, Mhaidat NM. An evaluation of the knowledge, opinions, expectations and concerns toward pharmacogenomics among Jordanian pharmacists. Pers Med. 2016;13(2):143–54.
Algahtani M. Knowledge, perception, and application of pharmacogenomics among hospital pharmacists in Saudi Arabia. Risk Manag Healthcare Policy. 2020;13:1279.
Benzeroual KE, Shah B, Shinde S. Pharmacogenomics: assessing educational exposure, confidence in knowledge and training elements of pharmacists. Pers Med. 2012;9(4):387–93.
Dodson C. Knowledge and attitudes concerning pharmacogenomics among healthcare professionals. Pers Med. 2011;8(4):421–8.
Elewa H, Alkhiyami D, Alsahan D, Abdel-Aziz A. A survey on the awareness and attitude of pharmacists and doctors towards the application of pharmacogenomics and its challenges in Q atar. J Eval Clin Pract. 2015;21(4):703–9.
Jarrar Y, Mosleh R, Hawash M, Jarrar Q. Knowledge and attitudes of pharmacy students towards pharmacogenomics among universities in Jordan and west bank of Palestine. Pharmacogenom Personal Med. 2019;12:247.
Pisanu C, Tsermpini E-E, Mavroidi E, Katsila T, Patrinos GP, Squassina A. Assessment of the pharmacogenomics educational environment in Southeast Europe. Public Health Genom. 2014;17(5–6):272–9.
Rahma AT, Elbarazi I, Ali BR, Patrinos GP, Ahmed LA, Al MF. Genomics and pharmacogenomics knowledge, attitude and practice of pharmacists working in United Arab Emirates: findings from focus group discussions—a qualitative study. J Personal Med. 2020;10(3):134.
Middleton A, Morley KI, Bragin E, Firth HV, Hurles ME, Wright CF, et al. Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing research. Eur J Hum Genet. 2016;24(1):21–9.
Hamilton JG, Shuk E, Genoff MC, Rodríguez VM, Hay JL, Offit K, et al. Interest and attitudes of patients with advanced cancer with regard to secondary germline findings from tumor genomic profiling. J Oncol Pract. 2017;13(7):e590–601.
Article PubMed PubMed Central Google Scholar
Faronbi JO, Faronbi GO, Ayamolowo SJ, Olaogun AA. Caring for the seniors with chronic illness: the lived experience of caregivers of older adults. Arch Gerontol Geriatr. 2019;82:8–14.
Comments (0)